REPL: Replimune Group Inc
今日REPL汇率已更改14.63%。当日,交易品种以低点6.82和高点8.10进行交易。
关注Replimune Group Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
REPL新闻
- Mirum Completes Enrollment & Screening in Liver Disease Studies
- Bayer Advances Roundup Settlement With Missouri Court Approval
- ESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75M
- Does Replimune Group (REPL) Have the Potential to Rally 79.61% as Wall Street Analysts Expect?
- MAHA Is Bringing Chaos to Biotech Investment Beyond Just Vaccines
- Replimune Stock: Multiple Shots On Goal But A High Risk Binary Approaches (NASDAQ:REPL)
- Wall Street Analysts Predict a 65.72% Upside in Replimune Group (REPL): Here's What You Should Know
- Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months
- Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
- Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
- The Short List — Top 10 Most Shorted Stocks Right Now - Lucid Group (NASDAQ:LCID)
- Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)
- Cantor Fitzgerald重申Replimune Group股票"增持"评级
- Cantor Fitzgerald reiterates Overweight rating on Replimune Group stock
- Replimune公布黑色素瘤治疗在SITC 2025的积极数据
- Replimune reports positive data for melanoma treatment at SITC 2025
- Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session - ALPS Group (NASDAQ:ALPS), Alvotech (NASDAQ:ALVO)
- BMO Capital上调Replimune股票评级,因FDA前景改善
- Replimune stock rating upgraded by BMO Capital on improved FDA outlook
- Tesla and Nvidia lead market cap stock movers this Tuesday
- H.C. Wainwright 上调 Replimune 股票评级至"买入",看好 RP1 获批前景
- H.C. Wainwright upgrades Replimune stock rating to Buy on RP1 approval chances
- This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Five Below (NASDAQ:FIVE), Booking Holdings (NASDAQ:BKNG)
- Replimune: Acceptance Confirms Completeness, Not Approval (NASDAQ:REPL)
常见问题解答
REPL股票今天的价格是多少?
Replimune Group Inc股票今天的定价为8.07。它在6.82 - 8.10范围内交易,昨天的收盘价为7.04,交易量达到4543。REPL的实时价格图表显示了这些更新。
Replimune Group Inc股票是否支付股息?
Replimune Group Inc目前的价值为8.07。股息政策取决于公司,而投资者也会关注-16.63%和USD。实时查看图表以跟踪REPL走势。
如何购买REPL股票?
您可以以8.07的当前价格购买Replimune Group Inc股票。订单通常设置在8.07或8.37附近,而4543和16.96%显示市场活动。立即关注REPL的实时图表更新。
如何投资REPL股票?
投资Replimune Group Inc需要考虑年度范围2.68 - 13.24和当前价格8.07。许多人在以8.07或8.37下订单之前,会比较8.18%和。实时查看REPL价格图表,了解每日变化。
Replimune Group Inc股票的最高价格是多少?
在过去一年中,Replimune Group Inc的最高价格是13.24。在2.68 - 13.24内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Replimune Group Inc的绩效。
Replimune Group Inc股票的最低价格是多少?
Replimune Group Inc(REPL)的最低价格为2.68。将其与当前的8.07和2.68 - 13.24进行比较,可以发现潜在的长期切入点。观看REPL在图表上的实时走势以获取更多详细信息。
REPL股票是什么时候拆分的?
Replimune Group Inc历史上曾经历过股票拆分。这些变化在公司行动后的、7.04和-16.63%中可见。
- 前一天收盘价
- 7.04
- 开盘价
- 6.90
- 卖价
- 8.07
- 买价
- 8.37
- 最低价
- 6.82
- 最高价
- 8.10
- 交易量
- 4.543 K
- 日变化
- 14.63%
- 月变化
- 8.18%
- 6个月变化
- 94.93%
- 年变化
- -16.63%